Concepedia

Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

Filip J. Baert, Geert D’Haens, Marc Peeters, Martin Hiele, T Schaible, David J. Shealy, Karel Geboes, Paul Rutgeerts

Gastroenterology · 1999 · 467 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

William R. Best, Jack M. Becktel, John W. Singleton et al. · PubMed · 1976 · 3.2K citations

, , +15

Development of a Crohn's Disease Activity Index

William R. Best, Jack M. Becktel, John W. Singleton et al. · Gastroenterology · 1976 · 3.2K citations

, , +12

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

, , +12

Immunol. Cell Biol.

Melinda Fitzgerald, Ian P. Hayward, Anita C. Thomas et al. · 1995 · 2.6K citations

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Hendrik M. van Dullemen, Sander J. H. van Deventer, Daan W. Hommes et al. · Gastroenterology · 1995 · 1.1K citations

, , +9